Identification of PTPN22 as a potential genetic biomarker for abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA) is a severe life-threatening disease that is generally asymptomatic and is diagnosed at a very late stage. The genetic component underpinning AAA is considerable, with an estimated heritability of up to 70%. Therefore, identifying genetic biomarkers for AAA is valuabl...
Main Authors: | Peng Ruan, Lei Gao, Hui Jiang, Tianshu Chu, Jianjun Ge, Xiang Kong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1061771/full |
Similar Items
-
Towards Precritical Medical Therapy of the Abdominal Aortic Aneurysm
by: Lucia Musumeci, et al.
Published: (2022-11-01) -
German nation-wide in-patient treatment of abdominal aortic aneurysm—trends between 2005 and 2019 and impact of the SARS-CoV-2 pandemic
by: Stefanie Bette, et al.
Published: (2023-08-01) -
Is Abdominal Aortic Aneurysm Behavior after Endovascular Repair Associated with Aneurysm Wall Density on Computed Tomography Angiography?
by: Arminas Skrebūnas, et al.
Published: (2019-07-01) -
Abdominal Aortic Aneurysm: Can the Anaconda™ Custom-Made Device Deliver? An International Perspective
by: Matti Jubouri, et al.
Published: (2022-07-01) -
Comparison of open surgery and endovascular treatment of asymptomatic juxta/pararenal abdominal aortic aneurysm
by: Zlatanović Petar, et al.
Published: (2023-01-01)